The fifth edition of “Cystic Fibrosis: Advances in Treatment and Care” provides an updated and expanded exploration of the remarkable progress made in the management of cystic fibrosis (CF) since the previous edition. Notable advancements include the development of targeted therapies that modulate the cystic fibrosis transmembrane conductance regulator (CFTR) protein, offering effective treatments for most CFTR gene abnormalities. This edition also addresses the profound impact of COVID-19 on CF care, further revolutionizing conventional models of treatment and support.
Key Features:
Comprehensive Coverage: This edition encompasses a wide range of topics, from fundamental science, including an in-depth understanding of the CFTR gene and protein, to innovative therapies and clinical management strategies. It addresses the needs of individuals with CF in high-, middle-, and low-income settings.
Multidisciplinary Perspective: Reflecting the collaborative nature of CF care, the book is designed to be a valuable reference for clinicians at all levels of training, scientists, students, and the entire multidisciplinary CF care team.
Global Expertise: The content is informed by the collective expertise of professionals and researchers from around the world who are engaged in cutting-edge clinical and basic science research. It presents best evidence-based practices from diverse international perspectives.
Organized Learning: Chapters are organized in a progressive manner, beginning with foundational knowledge before delving into more complex and evolving topics. This logical organization facilitates effective learning and comprehension for readers.
The fifth edition of “Cystic Fibrosis: Advances in Treatment and Care” offers a comprehensive, authoritative, and up-to-date resource that seamlessly integrates fundamental science with clinical aspects of CF. It is a valuable reference for anyone involved in the care, study, or treatment of cystic fibrosis, providing essential insights into the ongoing progress in this field.
